The drug, called icotrokinra and developed together with Protagonist Therapeutics, is an oral peptide designed to tamp down ...
As many companies scale back their inclusion efforts and as near-stagnant advancement of women in leadership positions continues, WXN (the Women's Executive Network) and its Global Alliance for ...